STAAR Surgical Company
Clinical trials sponsored by STAAR Surgical Company, explained in plain language.
A medical device company specializing in implantable lenses for vision correction.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new lens implant sharpen vision for nearsighted eyes? Results expected May 2027 (estimated)
- Can a single lens implant restore near and distance vision? Results expected May 2027 (estimated)
-
Can a single lens implant restore near and distance vision?
Disease control Not yet recruitingResearchers are testing a new type of implantable lens, called a diffractive trifocal phakic ICL, in adults aged 21 to 60 with myopia (nearsightedness) with or without astigmatism. The lens is surgically placed inside the eye to correct distance vision while also aiming to improv…
Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new lens implant sharpen vision for nearsighted eyes?
Disease control Not yet recruitingResearchers are testing a new type of implantable lens, called an aspheric ICL, to correct or reduce nearsightedness (myopia) with or without astigmatism. The lens is placed inside the eye during surgery and is designed to improve vision. This small study will include 10 people a…
Sponsor: Staar Surgical Company • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC